BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6154751)

  • 1. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR.
    Schmidt W; Festenstein H
    J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical analysis of a novel H-2 class I-like glycoprotein expressed in five AKR-(Gross virus) derived spontaneous T cell leukemias.
    Labeta MO; Fernandez N; Reyes A; Ferrara P; Marelli O; Le Roy E; Houlihan J; Festenstein H
    J Immunol; 1989 Aug; 143(4):1245-53. PubMed ID: 2473124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia.
    Schmidt W; Festenstein H; Atfield G
    Transplant Proc; 1980 Mar; 12(1):29-31. PubMed ID: 7368291
    [No Abstract]   [Full Text] [Related]  

  • 4. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes.
    Plata F; Tilkin AF; Lévy JP; Lilly F
    J Exp Med; 1981 Dec; 154(6):1795-810. PubMed ID: 6172533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of molecular species carrying gross cell surface antigen.
    Snyder HW; Stockert E; Fleissner E
    J Virol; 1977 Aug; 23(2):302-14. PubMed ID: 69725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia.
    Schmidt W; Festenstein H
    Immunogenetics; 1982; 16(3):257-64. PubMed ID: 6982849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F; Lilly F
    J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-2-specific antibodies induced by injection of syngeneic leukemia cells.
    Schmidt W
    Immunogenetics; 1987; 25(4):215-21. PubMed ID: 3570375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
    Hui KM; Sim T; Foo TT; Oei AA
    J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation of expression of histocompatibility antigens on tumor cells: absence of H-2Kk-gene products from a gross-virus-induced leukemia in BALB.K.
    Schmidt W; Leben L; Atfield G; Festenstein H
    Immunogenetics; 1981; 14(3-4):323-39. PubMed ID: 7333657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR
    Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface antigens associated with murine leukemia virus: definition of the GL and GT antigenic systems.
    Nowinski RC; Peters ED
    J Virol; 1973 Nov; 12(5):1104-17. PubMed ID: 4358163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alien H-2 allospecificities in murine chemically-induced tumors.
    Merino F
    Immunol Commun; 1979; 8(5-6):555-62. PubMed ID: 94037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.